Molecular Studies and Clinical Correlations in Human Prostatic Disease

Summary

The Genitourinary Oncology/Urology Services at Memorial Sloan-Kettering Cancer Center (MSKCC) participates in research for the control, treatment, and cure of cancer. The purpose of this study is to collect normal and cancerous tissues, in addition to blood, and other body fluid samples from men with prostate cancer or prostatic disease. These samples may be stored for future use or used immediately by researchers who study prostate cancer and try to find better ways to diagnose, prevent, and treat it. We will look for genetic changes and protein markers on these cells. We hope to learn more about what makes some people get prostate cancer, why some cancers are more aggressive than others, and why some cancers respond to or resist different treatments. We may also try to grow the tumor cells in the lab. We may find a new treatment for prostate cancer based on this research.

Conditions

• Prostate Cancer

Sponsors & Collaborators

• Rockefeller University

  collaborator OTHER

• Flinders Medical Centre

  collaborator OTHER_GOV

• University of Southern California

  collaborator OTHER

• Gen-Probe, Incorporated

  collaborator INDUSTRY

• Genentech, Inc.

  collaborator INDUSTRY

• General Electric

  collaborator INDUSTRY

• Purdue University

  collaborator OTHER

• Biocept, Inc.

  collaborator INDUSTRY

• Duke University

  collaborator OTHER

• Ikonysis

  collaborator INDUSTRY

• Array Genomics

  collaborator INDUSTRY

• Cold Spring Harbor Laboratory

  collaborator OTHER

• Nodality

  collaborator INDUSTRY

• Epic Sciences

  collaborator INDUSTRY

• Rutgers Cancer Institute of New Jersey

  collaborator OTHER

• Dana-Farber Cancer Institute

  collaborator OTHER

• Johns Hopkins University

  collaborator OTHER

• M.D. Anderson Cancer Center

  collaborator OTHER

• Oregon Health and Science University

  collaborator OTHER

• University of California, San Francisco

  collaborator OTHER

• University of Chicago

  collaborator OTHER

• University of Michigan

  collaborator OTHER

• University of Washington

  collaborator OTHER

• University of Wisconsin, Madison

  collaborator OTHER

• Fred Hutchinson Cancer Center

  collaborator OTHER

• Broad Institute of MIT and Harvard

  collaborator OTHER

• Weill Medical College of Cornell University

  collaborator OTHER

• Institute of Cancer Research, United Kingdom

  collaborator OTHER

• Vitatex Inc.

  collaborator INDUSTRY

• Serametrix Corporation

  collaborator INDUSTRY

• Promega Corporation

  collaborator INDUSTRY

• Creatv Microtech, Inc.

  collaborator OTHER

• Viatar LLC

  collaborator INDUSTRY

• Massachusetts Institute of Technology

  collaborator OTHER

• Advanced Cell Diagnostics

  collaborator INDUSTRY

• ApoCell, Inc.

  collaborator INDUSTRY

• Beckman Coulter GmbH

  collaborator INDUSTRY

• Bioview, Inc.

  collaborator INDUSTRY

• Clearbridge BioMedics Pte Ltd., Singapore

  collaborator INDUSTRY

• Cynvenio Biosystems

  collaborator INDUSTRY

• Exosome Diagnostics, Inc.

  collaborator INDUSTRY

• Fluxion Biosciences

  collaborator INDUSTRY

• Foundation Medicine

  collaborator INDUSTRY

• Universitätsklinikum Hamburg-Eppendorf

  collaborator OTHER

• Brooklyn ImmunoTherapeutics, LLC

  collaborator INDUSTRY

• Ohio State University

  collaborator OTHER

• Palo Alto Research Center

  collaborator OTHER

• Rarecells

  collaborator INDUSTRY

• Silicon Biosystems

  collaborator INDUSTRY

• The Scripps Research Institute

  collaborator OTHER

• University of Minnesota

  collaborator OTHER

• Janssen Diagnostics, LLC

  collaborator INDUSTRY

• University of Regensburg

  collaborator OTHER

• Innocrin Pharmaceuticals Inc.

  collaborator INDUSTRY

• Memorial Sloan Kettering Cancer Center

  lead OTHER

Principal Investigators

• Susan Slovin, MD · Memorial Sloan Kettering Cancer Center

Eligibility

Sex

MALE

Healthy Volunteers

No

Timeline & Regulatory

Start

1990-04-30

Primary Completion

2026-12-31

Completion

2026-12-31

Countries

• United States

Study Locations